Specialty Healthcare Benefits Council

On behalf of the Specialty
Healthcare Benefits Council, I would like to highlight our mission and invite your collaboration.
As the development of specialty health products and services increases, we see the parallel need for responsible accountability. We seek to ensure utilization is appropriate and clinically sound. By bringing together the community of stakeholders, we look to provide pathways to allow sustainable use of these products. And as the marketplace evolves, we seek to define future benefit options, distribution systems, and management tools to weave together the benefit systems that deliver the right product to the right patient at the right time. Effective use of specialty health products and services occurs only when value is clear and consistent with scientific evidence. We seek value through the balance of cost, access, and quality. As a nonprofit organization, we provide a forum for collaboration among payers, developers, vendors, and supporters in this dynamic marketplace.
James A. Jorgenson, RPh, MS, FASHP
Announcing a new CE program, “Individualizing HIV Care to Optimize Patient Outcomes”
This one-hour CE program has been developed by the Specialty Healthcare Benefits Council in collaboration with the University of Chicago Pritzker School of Medicine (Continuing Medical Education) and Vindico Medical Education (Continuing Pharmacy Education). It is supported by an educational grant from Janssen Therapeutics, a division of Janssen Products, LP.

to register, log in, and access the program, downloadable slides, and post-test.
Announcing an education program on improving the cost effective management of hemophilia in a managed care settting
for the original 2014 CE program, "Challenges and Opportunities for Managing Hemophilia," and original CE test, valid through 2016.
for the 2011 journal article and 2013 Webcast slides and scripts to gauge further learning.
Other related materials appear in the Resources section.
Implications of STeP for Improved Diabetes Control: A Payer Perspective
The Specialty Healthcare Benefits Council (formerly the Pharmacy & Therapeutics Society) recently supported the above article on diabetes management that has been published in the America Journal of Pharmacy Benefits (AJPB).
To view the article,